HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension.

Abstract
Fibrosis is an important component of large conduit artery disease in hypertension. The endogenous tetrapeptide N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) has anti-inflammatory and antifibrotic effects in the heart and kidney. However, it is not known whether Ac-SDKP has an anti-inflammatory and antifibrotic effect on conduit arteries such as the aorta. We hypothesize that in ANG II-induced hypertension Ac-SDKP prevents aortic fibrosis and that this effect is associated with decreased protein kinase C (PKC) activation, leading to reduced oxidative stress and inflammation and a decrease in the profibrotic cytokine transforming growth factor-beta1 (TGF-beta1) and phosphorylation of its second messenger Smad2. To test this hypothesis we used rats with ANG II-induced hypertension and treated them with either vehicle or Ac-SDKP. In this hypertensive model we found an increased collagen deposition and collagen type I and III mRNA expression in the aorta. These changes were associated with increased PKC activation, oxidative stress, intercellular adhesion molecule (ICAM)-1 mRNA expression, and macrophage infiltration. TGF-beta1 expression and Smad2 phosphorylation also increased. Ac-SDKP prevented these effects without decreasing blood pressure or aortic hypertrophy. Ac-SDKP also enhanced expression of inhibitory Smad7. These data indicate that in ANG II-induced hypertension Ac-SDKP has an aortic antifibrotic effect. This effect may be due in part to inhibition of PKC activation, which in turn could reduce oxidative stress, ICAM-1 expression, and macrophage infiltration. Part of the effect of Ac-SDKP could also be due to reduced expression of the profibrotic cytokine TGF-beta1 and inhibition of Smad2 phosphorylation.
AuthorsChun-Xia Lin, Nour-Eddine Rhaleb, Xiao-Ping Yang, Tang-Dong Liao, Martin A D'Ambrosio, Oscar A Carretero
JournalAmerican journal of physiology. Heart and circulatory physiology (Am J Physiol Heart Circ Physiol) Vol. 295 Issue 3 Pg. H1253-H1261 (Sep 2008) ISSN: 0363-6135 [Print] United States
PMID18641275 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Oligopeptides
  • Smad2 Protein
  • Transforming Growth Factor beta1
  • Vasoconstrictor Agents
  • Angiotensin II
  • Intercellular Adhesion Molecule-1
  • Collagen
  • Elastin
  • Protein Kinase C
  • goralatide
Topics
  • Angiotensin II
  • Animals
  • Aorta (pathology)
  • Collagen (biosynthesis, genetics, metabolism)
  • Elastin (metabolism)
  • Enzyme Activation (drug effects)
  • Fibrosis
  • Heart Diseases (etiology, pathology, prevention & control)
  • Hypertension (chemically induced, complications, pathology)
  • Immunohistochemistry
  • Intercellular Adhesion Molecule-1 (biosynthesis)
  • Lipid Metabolism (drug effects)
  • Male
  • Neutrophil Infiltration (drug effects)
  • Oligopeptides (pharmacology)
  • Oxidation-Reduction
  • Phosphorylation
  • Protein Kinase C (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Smad2 Protein (metabolism)
  • Transforming Growth Factor beta1 (biosynthesis, genetics)
  • Vasoconstrictor Agents

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: